 Erika Lasda
Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trans-Splicing | 4 | 2011 | 15 | 1.150 |
Why?
| | RNA, Spliced Leader | 4 | 2011 | 12 | 0.840 |
Why?
| | RNA | 3 | 2016 | 809 | 0.690 |
Why?
| | Caenorhabditis elegans | 3 | 2011 | 268 | 0.630 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 57 | 0.490 |
Why?
| | Viroids | 1 | 2014 | 2 | 0.480 |
Why?
| | Exosomes | 1 | 2016 | 92 | 0.480 |
Why?
| | RNA Precursors | 3 | 2011 | 136 | 0.460 |
Why?
| | RNA Splicing | 2 | 2014 | 245 | 0.440 |
Why?
| | Ribonucleoproteins, Small Nuclear | 2 | 2010 | 23 | 0.420 |
Why?
| | Alternative Splicing | 6 | 2008 | 187 | 0.410 |
Why?
| | Virus Replication | 1 | 2014 | 395 | 0.400 |
Why?
| | Cell Extracts | 1 | 2011 | 15 | 0.370 |
Why?
| | Carrier State | 2 | 2021 | 54 | 0.360 |
Why?
| | Asymptomatic Infections | 2 | 2021 | 21 | 0.240 |
Why?
| | Therapeutics | 1 | 2004 | 12 | 0.230 |
Why?
| | Viral Load | 2 | 2021 | 405 | 0.210 |
Why?
| | Saliva | 2 | 2021 | 188 | 0.210 |
Why?
| | Base Sequence | 5 | 2011 | 2114 | 0.200 |
Why?
| | Nucleic Acid Conformation | 3 | 2014 | 669 | 0.180 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 688 | 0.150 |
Why?
| | Holoenzymes | 1 | 2018 | 21 | 0.150 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2018 | 156 | 0.150 |
Why?
| | Chemical Precipitation | 1 | 2016 | 37 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 1 | 2004 | 2087 | 0.130 |
Why?
| | Introns | 2 | 2014 | 227 | 0.120 |
Why?
| | Cytoplasm | 1 | 2016 | 255 | 0.120 |
Why?
| | RNA Splice Sites | 1 | 2014 | 33 | 0.120 |
Why?
| | Exons | 3 | 2018 | 302 | 0.120 |
Why?
| | Evolution, Molecular | 2 | 2011 | 430 | 0.110 |
Why?
| | Operon | 2 | 2011 | 59 | 0.110 |
Why?
| | Receptors, Fibroblast Growth Factor | 2 | 2003 | 63 | 0.110 |
Why?
| | Animals | 11 | 2023 | 31710 | 0.100 |
Why?
| | Molecular Sequence Data | 4 | 2011 | 2785 | 0.100 |
Why?
| | Cell Line | 2 | 2016 | 2637 | 0.100 |
Why?
| | Spliceosomes | 1 | 2011 | 38 | 0.090 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2008 | 21 | 0.090 |
Why?
| | Inverted Repeat Sequences | 1 | 2010 | 13 | 0.090 |
Why?
| | Consensus Sequence | 1 | 2010 | 70 | 0.090 |
Why?
| | Uridine | 1 | 2010 | 29 | 0.090 |
Why?
| | RNA Stability | 1 | 2011 | 90 | 0.090 |
Why?
| | Universities | 2 | 2021 | 341 | 0.080 |
Why?
| | MicroRNAs | 1 | 2014 | 600 | 0.080 |
Why?
| | Phylogeny | 1 | 2011 | 789 | 0.070 |
Why?
| | Enhancer Elements, Genetic | 1 | 2008 | 151 | 0.070 |
Why?
| | Brain | 1 | 2018 | 2371 | 0.070 |
Why?
| | Computational Biology | 1 | 2010 | 530 | 0.070 |
Why?
| | Sodium Channels | 1 | 2006 | 62 | 0.070 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 172 | 0.060 |
Why?
| | Actin Cytoskeleton | 1 | 2006 | 93 | 0.060 |
Why?
| | Actins | 1 | 2006 | 381 | 0.060 |
Why?
| | Rats | 5 | 2018 | 4959 | 0.060 |
Why?
| | RNA-Binding Proteins | 1 | 2007 | 345 | 0.060 |
Why?
| | Models, Biological | 1 | 2011 | 1621 | 0.060 |
Why?
| | Zebrafish Proteins | 1 | 2006 | 247 | 0.060 |
Why?
| | Pandemics | 2 | 2021 | 1320 | 0.050 |
Why?
| | Zebrafish | 1 | 2006 | 412 | 0.050 |
Why?
| | Listeria monocytogenes | 1 | 2023 | 111 | 0.050 |
Why?
| | Humans | 9 | 2021 | 114711 | 0.050 |
Why?
| | Protein Transport | 2 | 2018 | 395 | 0.050 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2003 | 226 | 0.050 |
Why?
| | Immunologic Memory | 1 | 2023 | 313 | 0.050 |
Why?
| | Protein Isoforms | 2 | 2018 | 338 | 0.050 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 34 | 0.050 |
Why?
| | Virion | 1 | 2021 | 73 | 0.050 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2021 | 92 | 0.040 |
Why?
| | Specimen Handling | 1 | 2021 | 156 | 0.040 |
Why?
| | Mice | 4 | 2023 | 14872 | 0.040 |
Why?
| | RNA, Viral | 1 | 2021 | 565 | 0.040 |
Why?
| | Students | 1 | 2021 | 502 | 0.030 |
Why?
| | Protein Domains | 1 | 2018 | 207 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2018 | 270 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1695 | 0.030 |
Why?
| | Phenotype | 1 | 2004 | 2797 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2023 | 1701 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2018 | 2553 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1528 | 0.030 |
Why?
| | Mesoderm | 2 | 2008 | 138 | 0.030 |
Why?
| | Mass Screening | 1 | 2021 | 1006 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2023 | 4694 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2007 | 1982 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 1752 | 0.030 |
Why?
| | Colorado | 1 | 2021 | 4100 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2006 | 801 | 0.020 |
Why?
| | Globins | 1 | 2008 | 21 | 0.020 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 1 | 2008 | 4 | 0.020 |
Why?
| | Organ Specificity | 1 | 2008 | 268 | 0.020 |
Why?
| | RNA, Helminth | 1 | 2007 | 17 | 0.020 |
Why?
| | Genes, Helminth | 1 | 2007 | 26 | 0.020 |
Why?
| | Epithelium | 1 | 2008 | 295 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10472 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 5520 | 0.020 |
Why?
| | HeLa Cells | 1 | 2008 | 562 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2006 | 95 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 353 | 0.020 |
Why?
| | COS Cells | 1 | 2006 | 175 | 0.020 |
Why?
| | Chickens | 1 | 2006 | 177 | 0.020 |
Why?
| | Ion Channel Gating | 1 | 2006 | 83 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2006 | 173 | 0.020 |
Why?
| | Isoenzymes | 1 | 2006 | 283 | 0.020 |
Why?
| | Larva | 1 | 2006 | 194 | 0.020 |
Why?
| | Protein Subunits | 1 | 2006 | 201 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2003 | 167 | 0.010 |
Why?
| | Sea Urchins | 1 | 2003 | 7 | 0.010 |
Why?
| | Plasmids | 1 | 2003 | 343 | 0.010 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2003 | 48 | 0.010 |
Why?
| | Phosphorylation | 1 | 2006 | 1569 | 0.010 |
Why?
| | Transfection | 1 | 2003 | 866 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2006 | 2219 | 0.010 |
Why?
| | Myocardium | 1 | 2006 | 913 | 0.010 |
Why?
| | Protein Binding | 1 | 2006 | 1890 | 0.010 |
Why?
| | Models, Genetic | 1 | 2003 | 562 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 2003 | 723 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1518 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2003 | 951 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2003 | 2320 | 0.010 |
Why?
| | Female | 1 | 2018 | 59573 | 0.010 |
Why?
|
|
Lasda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|